Completed NA INTERVENTIONAL 2-arm NCT05160220

Naturalistic Study of Microdosing With Psilocybin (NATMICRO)

Double-blind Placebo-controlled Naturalistic Study of Microdosing With Psilocybin: Effects on Brain Activity, Behavior, Cognition, Creativity, and Mental Health

Sponsor: National Council of Scientific and Technical Research, Argentina

Conditions Cognitive Change Creativity Mood Change Sleep

Interventions Placebo Psilocybin

Updated 3 times since 2022 Last updated: Dec 3, 2021 Started: Jan 20, 2021 Primary completion: Jun 30, 2021 Completion: Oct 1, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Cognitive Change and Creativity, this trial is completed. The trial is conducted by National Council of Scientific and Technical Research, Argentina and has accumulated 3 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2022 — Jul 2024 [monthly]

Completed NA

First recorded

Jan 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Council of Scientific and Technical Research, Argentina

Data source: National Council of Scientific and Technical Research, Argentina

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Buenos Aires, Argentina